gleason score
Recently Published Documents


TOTAL DOCUMENTS

1736
(FIVE YEARS 356)

H-INDEX

67
(FIVE YEARS 7)

Author(s):  
Stephanie Navarro ◽  
Xiaohui Hu ◽  
Aaron Mejia ◽  
Carol Y. Ochoa ◽  
Trevor A. Pickering ◽  
...  

2022 ◽  
Vol 12 (1) ◽  
Author(s):  
Hideya Yamazaki ◽  
Gen Suzuki ◽  
Norihiro Aibe ◽  
Daisuke Shimizu ◽  
Takuya Kimoto ◽  
...  

AbstractAs several recent researches focus on the importance of Gleason 9–10, we examine the role of radiotherapy dose escalation in those patients. We analyzed 476 patients with Gleason score 9–10 prostate cancer treated with radiotherapy. Of them, 127 patients were treated with conventional-dose external beam radiotherapy (Conv RT) and 349 patients were treated with high-dose radiotherapy (HDRT; 249 patients received high-dose-rate brachytherapy boost + external beam radiotherapy [HDR boost] and 100 patients received intensity-modulated radiotherapy [IMRT]). We compared these treatment groups using multi-institutional retrospective data. The patients had a median follow-up period of 66.3 months. HDRT showed superior biochemical disease-free survival (bDFS) rate (85.2%; HDR boost 84.7% and IMRT 86.6%) to Conv RT (71.1%, p < 0.0001) at 5 years, with a hazard ratio of 0.448. There were borderline difference in prostate cancer-specific mortality (PCSM; 4.3% and 2.75%, p = 0.0581), and distant metastasis-free survival (DMFS; 94.4% and 89.6%, p = 0.0916) rates at 5-years between Conv RT and HDRT group. Dose escalated radiotherapy showed better bDFS, borderline improvement in PCSM, and equivocal outcome in DMFS in with clinically localized Gleason 9–10 prostate cancer.


2022 ◽  
Vol 3 (1) ◽  
pp. 01-05
Author(s):  
Omar Alqawi ◽  
Eman Elshahmi ◽  
Fatma Emaetig ◽  
Fauzia Elgaraboli ◽  
Abubaker Abushnaf

Background: Prostate cancer is the second most frequent cancer and the fifth leading cause of cancer death in men with higher prevalence in the developed countries. The use of biomarkers for prostate cancer can improve the diagnosis of prostate cancer and clinical management of the patients. Prostate-specific antigen (PSA) is widely used to screen for prostate cancer and there is evidence that PSA testing reduces prostate cancer mortality. Objective: In this report we have studied the relationship between the Gleason score, age and PSA levels of prostate adenocarcinoma tissues from Libyan patients to evaluate the levels of PSA in prostate cancer patients. Materials and methods: The data was collected from medical files of 40 patients who underwent curative surgical prostatectomy or prostate true cut biopsy at National Cancer Institute (NCI)-Misurata, Libya during 2016 to 2018. The clinical and histopathological information included age, PSA levels, and Gleason score grade. Results: Our data showed that PSA level was statistically significant correlation with Gleason score grade (p- value = 0.007, <0.05). The increased serum PSA level was associated with the progression of prostate cancer. However, we found no statistically significant correlation between PSA and the age of patients (p- value = 0.435). Conclusion: Our data confirmed the association of high levels of PSA and the progress of prostate cancer.


2021 ◽  
Vol 2021 ◽  
pp. 1-8
Author(s):  
Yong Wei ◽  
Hongru Zhu ◽  
Peng Chen ◽  
Wenren Zuo ◽  
Wenhui Qian ◽  
...  

This study was to explore the correlation between the malignant degree of prostate cancer (PCa) and body mass index (BMI) mediated by ultrasound images under multioperator algorithm (MOA) based on minimum variance (MV) algorithm. MOA was established by optimizing the smoothing technique and diagonal loading algorithms of MV, and its quality and processing speed of ultrasound images were compared with other algorithms. Ninety two patients were selected as the subjects investigated, who had transrectal prostate biopsy mediated by ultrasound to be diagnosed as PCa in the hospital. Based on Gleason score and prostate specific antigen (PSA) value, all patients were divided into a high-risk PCa group (a high-risk group) and a non-high-risk PCa group (a non-high-risk group). The proportion of obese patients in the two groups was compared. The logistic regression analysis method was applied to analyze related factors of PCa development, and Pearson correlation was for analyzing the correlation between Gleason score and BMI of patients. The results showed that the number of patients in the high-risk group was greater than that of the non-high-risk group ( P  < 0.05), while the proportion of nonobese patients in the non-high-risk group was markedly higher than that of the higher-risk group ( P  < 0.01). Both PSA and BMI were obviously correlated with the development of high-risk PCa ( P  < 0.05), and there was an extreme positive correlation between BMI and Gleason score (r = 0.661 and P  = 0.007). It indicated that MOA was established based on conventional MV, which could increase the ultrasonic image quality and calculation speed. Besides, BMI was a risk factor of high-risk PCa and was positively correlated with malignant degree of PCa, which provided a referable evidence for clinical evaluation of malignant degree of PCa.


2021 ◽  
pp. 1-5
Author(s):  
Xue-fei Ding ◽  
Yang Luan ◽  
An-le Xia ◽  
Liang-yong Zhu ◽  
Qin Xiao ◽  
...  

<b><i>Background:</i></b> The aim of this study was to evaluate the clinical value of 16 G biopsy needle in transperineal template-guided prostate biopsy (TTPB), compared with 18 G biopsy needle. <b><i>Methods:</i></b> The patients who underwent TTPB from August 2020 to February 2021 were randomized into 2 groups using a random number table. The control group (<i>n</i> = 65) and the observation group (<i>n</i> = 58) performed biopsy with 18 G (Bard MC l820) and 16 G (Bard MC l616) biopsy needles, respectively. Positive rate of biopsy, Gleason score, complications, and pain score were statistically analyzed. <b><i>Results:</i></b> The age, prostate volume, PSA, and the number of cores were comparable between the 2 groups. The positive rate of biopsy in the observation group was 68.9% (40/58), meanwhile the control group was 46.2% (30/65). There was statistical difference between the 2 groups (<i>p</i> = 0.011). Gleason score of the observation group (8 [7–9]) was higher than that of the control group (8 [6–9]) (<i>p</i> = 0.038). There was no significant difference in pain score and complications including hematuria, hematospermia, perineal hematoma, infection, and urinary retention between the 2 groups (<i>p</i> &#x3e; 0.05). <b><i>Conclusions:</i></b> 16 G biopsy needle significantly improved the positive rates and accurately evaluate the nature of lesions, meanwhile did not increase the incidence of complications compared with 18 G biopsy needle.


2021 ◽  
Vol 8 ◽  
Author(s):  
Mike Wenzel ◽  
Felix Preisser ◽  
Benedikt Hoeh ◽  
Maria N. Welte ◽  
Clara Humke ◽  
...  

Objective: To analyze the influence of biopsy Gleason score on the risk for lymph node invasion (LNI) during pelvic lymph node dissection (PLND) in patients undergoing radical prostatectomy (RP) for intermediate-risk prostate cancer (PCa).Materials and Methods: We retrospectively analyzed 684 patients, who underwent RP between 2014 and June 2020 due to PCa. Univariable and multivariable logistic regression, as well as binary regression tree models were used to assess the risk of positive LNI and evaluate the need of PLND in men with intermediate-risk PCa.Results: Of the 672 eligible patients with RP, 80 (11.9%) men harbored low-risk, 32 (4.8%) intermediate-risk with international society of urologic pathologists grade (ISUP) 1 (IR-ISUP1), 215 (32.0%) intermediate-risk with ISUP 2 (IR-ISUP2), 99 (14.7%) intermediate-risk with ISUP 3 (IR-ISUP3), and 246 (36.6%) high-risk PCa. Proportions of LNI were 0, 3.1, 3.7, 5.1, and 24.0% for low-risk, IR-ISUP1, IR-ISUP 2, IR-ISUP-3, and high-risk PCa, respectively (p &lt; 0.001). In multivariable analyses, after adjustment for patient and surgical characteristics, IR-ISUP1 [hazard ratio (HR) 0.10, p = 0.03], IR-ISUP2 (HR 0.09, p &lt; 0.001), and IR-ISUP3 (HR 0.18, p &lt; 0.001) were independent predictors for lower risk of LNI, compared with men with high-risk PCa disease.Conclusions: The international society of urologic pathologists grade significantly influence the risk of LNI in patients with intermediate- risk PCa. The risk of LNI only exceeds 5% in men with IR-ISUP3 PCa. In consequence, the need for PLND in selected patients with IR-ISUP 1 or IR-ISUP2 PCa should be critically discussed.


2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Adrianna Jiaying Lee ◽  
Amelia Wnorowski ◽  
Nancy Ye ◽  
Linhan Xu ◽  
Michael Naslund ◽  
...  

2021 ◽  
pp. 42-47
Author(s):  
Pogula Veda Murthy Reddy ◽  
Omkaram Karthikesh ◽  
Galeti Ershad Hussain ◽  
Kanchi V Bhargava Reddy

Background Prostate cancer is the second most common cancer and the fifth leading cause of cancer deaths worldwide. Serum psa, a glycoprotein and a serine protease, which is increased in all prostatic diseases but markedly elevated levels are indicative of carcinoma prostate. The present study was done to evaluate the histopathologyof carcinoma of prostate in trus guided prostatic biopsy specimens and correlate serum psa levels with gleason score and grade groups. Methods A hundred patients presented with luts and suspicious of carcinoma prostate underwent trus guided 16 core prostatic biopsy. Histopathological examination, gleason scores and grades of biopsies were obtained. Based on the gleason scores, patients with carcinoma of the prostate were divided into five-grade groups. Mean serum psa levels were calculated and correlated with gleason score and grade groups. Results Malignancy was found in 69 per cent of cases, of which 68 patients were found to have adenocarcinoma of the prostate, one patient found to have undifferentiated carcinoma of the prostate. The total number of patients in each gleason grade groups were obtained, and the mean serum psa levels of these patients in each group were calculated. Mean serum psa levels in each group are group 1 (21.3 ng/ml), group 2 (58.4 ng/ml), group 3 (73.6 ng/ml), group 4 (118.4 ng/ml), group 5 (96.3 ng/ml). Conclusion Serum psa is a highly sensitive tumour marker with low specificity, and its levels are increased in many benign and iatrogenic conditions. Psa has a high negative predictive value which is essential in ruling out malignancy. In our study, higher serum psa levels were correlated with higher gleason score and grades.


Cancers ◽  
2021 ◽  
Vol 13 (23) ◽  
pp. 6065
Author(s):  
Ana Rodrigues ◽  
João Santinha ◽  
Bernardo Galvão ◽  
Celso Matos ◽  
Francisco M. Couto ◽  
...  

Prostate cancer is one of the most prevalent cancers in the male population. Its diagnosis and classification rely on unspecific measures such as PSA levels and DRE, followed by biopsy, where an aggressiveness level is assigned in the form of Gleason Score. Efforts have been made in the past to use radiomics coupled with machine learning to predict prostate cancer aggressiveness from clinical images, showing promising results. Thus, the main goal of this work was to develop supervised machine learning models exploiting radiomic features extracted from bpMRI examinations, to predict biological aggressiveness; 288 classifiers were developed, corresponding to different combinations of pipeline aspects, namely, type of input data, sampling strategy, feature selection method and machine learning algorithm. On a cohort of 281 lesions from 183 patients, it was found that (1) radiomic features extracted from the lesion volume of interest were less stable to segmentation than the equivalent extraction from the whole gland volume of interest; and (2) radiomic features extracted from the whole gland volume of interest produced higher performance and less overfitted classifiers than radiomic features extracted from the lesions volumes of interest. This result suggests that the areas surrounding the tumour lesions offer relevant information regarding the Gleason Score that is ultimately attributed to that lesion.


Sign in / Sign up

Export Citation Format

Share Document